Skip to main content

Table 3 Comparison of the automated method with manual analysis shows acceptable agreement

From: Ranked retrieval of segmented nuclei for objective assessment of cancer gene repositioning

Dataset Type # Nuclei Manual FRA2 Auto FRA2 Manual HES5 Auto HES5 Agree FRA2 Agree HES5
D1 NCBD 63 0.1132 0.1918 0.1363 0.1321
D2 Cancer 164 0.2689 0.4360 0.0000 0.0000
D3 Cancer 115 0.0050 0.0001 0.0003 0.0000
D4 Cancer 133 0.0000 0.0001 0.0000 0.0000
D5 Cancer 188 0.0237 0.0000 0.0000 0.0000 X
D6 Cancer 147 0.0004 0.0182 0.5239 0.5019 X
D7 Cancer 63 0.0000 0.0000 0.0724 0.0013 X
D8 Cancer 174 0.0002 0.0000 0.3017 0.3576
D9 Cancer 120 0.0000 0.0000 0.0000 0.0000
D10 Cancer 117 0.0001 0.0005 0.0157 0.0201
D11 Cancer 87 0.0001 0.0007 0.0000 0.0286 X
D12 Cancer 153 0.0009 0.0048 0.0000 0.0130 X
D13 Cancer 37 0.0000 0.0004 0.0526 0.9827
       Total: 11/13 10/13
        84.60% 76.90%
  1. a13 test datasets with their tissue type (NCBD = non-cancerous breast disease) and the number of nuclei screened with a probability above 0.1.